Rocket Pharmaceuticals, Inc.

RCKT· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$3.37-3.71%

2026-09-18

Financials

Valuation Metrics

Rocket Pharmaceuticals, Inc.'s Market Cap is $368M. At end of 2025 it was $390M. Ranked #2886 of 3,121 in US market (top 92%), #1286 of 1,463 on NASDAQ (top 88%), #233 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 88%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$368M	US#2,886/3,121 Sec#233/266
Revenue	$0.00	US#2,889/3,121 Sec#196/266
Net Income	$-17M	US—/3,121 Sec—/266
Total Assets	$423M	US#2,826/3,121 Sec#180/266
Net Assets	$369M	US#2,428/3,121 Sec#144/266
Value
P/B	1.00x	US#411/3,121 Sec#13/266
EV/EBITDA	21.16x	US#2,022/3,121 Sec#53/266
FCF Yield	-46.31%	US—/3,121 Sec—/266
Profitability
ROE	-4.68%	US#2,257/3,121 Sec#73/266
ROA	-4.08%	US#2,488/3,121 Sec#82/266
Financial Health
Debt Ratio	14.71%	US#174/3,121 Sec#69/266
Total Debt	$25M	US#2,724/3,121 Sec#181/266
FCF	$-170M	US#2,747/3,121 Sec#194/266
Cash	$225M	US#1,644/3,121 Sec#98/266
Current Ratio	9.24x	US#282/3,121 Sec#86/266
Net Debt/EBITDA	-25.12x	US#12/3,121 Sec#2/266
Performance
1Y Return	6.31%	US#1,302/3,121 Sec#162/266
1M Return	-7.67%	US#503/3,121 Sec#55/266
From 52W High	-38.17%	US#2,334/3,121 Sec#179/266
1Y MDD	-50.94%	US#2,502/3,121 Sec#186/266
Trading
Volume	1,529,876 shares	US#875/3,121 Sec#90/266
Trading Value	$5M	US#2,552/3,121 Sec#214/266
Per Share
EPS	$-0.16	US—/3,121 Sec—/266
BPS	$3.38	US#2,445/3,121 Sec#158/266